Involving Nucleic Acid Patents (Class 435/6.1)
  • Patent number: 11661587
    Abstract: Disclosed are luciferase polypeptides with improved light-emitting activity and their encoding nucleic acids. These molecules are useful in a range of assays including luciferase-based gene reporter assays, bioluminescence resonance energy transfer assays, protein complementation assays and other applications in which luciferase enzymes are utilized as detectable and/or quantifiable labels. Also disclosed are methods and compositions for increasing the sensitivity and/or improving the kinetics of luciferase-catalyzed reactions as well as decreasing the impact of undesirable variables.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: May 30, 2023
    Assignee: Promega Corporation
    Inventors: John Michael Daly, Leon Michael Brownrigg, Jim Yu-Hsiang Tiao
  • Patent number: 11661600
    Abstract: In certain embodiments, the present invention provides a modified transfer RNA (tRNA) comprising a T-arm, a D-arm, and anticodon-arm and an acceptor arm, wherein the T-arm comprises nucleotides that interact with the elongation factor 1 alpha protein, and methods of use thereof.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: May 30, 2023
    Inventors: Christopher Ahern, John D. Lueck
  • Patent number: 11655458
    Abstract: Embodiments of the present disclosure provide a target capturing apparatus and a manufacturing method thereof, and a target detecting method. The target capturing apparatus includes a cavity structure, the cavity structure includes: an inlet portion, an outlet portion and a capture region positioned between the inlet portion and the outlet portion, and the capture region includes a capture component, and a combination specifically combined with a to-be-captured target is included in the capture component so as to capture the target in a sample entering the cavity structure.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: May 23, 2023
    Inventor: Defeng Mao
  • Patent number: 11655473
    Abstract: Oligonucleotides are provided herein that inhibit MARC1 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with MARC1 expression.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: May 23, 2023
    Assignees: Novo Nordisk A/S, Dicerna Pharmaceuticals, Inc.
    Inventors: Henryk Dudek, Wen Han, Natalie Wayne Pursell, Chengjung Lai, William Geoffrey Haynes, Zhihao Ding
  • Patent number: 11649457
    Abstract: The present disclosure provides small hairpin nucleic acid molecules capable of stimulating interferon production. The nucleic acid molecules of the present disclosure has a double-stranded section of less than 19 base pairs and at least one blunt end. In certain embodiments, the molecule comprises at least one 5?-triphosphate and/or at least one 5?-diphosphate. In certain embodiments, compounds and/or compositions of the disclosure are useful for treating, ameliorating, and/or preventing SARS-CoV-2 viral infection, and/or ameliorating, minimizing, reversing, and/or preventing persistent SARS-CoV-2 viral infection, and/or minimizing or preventing SARS-CoV-2 viral infection-derived mortality and/or lethality, in a subject. In certain embodiments, compounds and/or compositions of the disclosure are useful for treating, ameliorating, and/or preventing SARS-CoV-2 viral infection in a tumor-bearing subject.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: May 16, 2023
    Assignee: Yale University
    Inventors: Anna Marie Pyle, Akiko Iwasaki, Tianyang Mao
  • Patent number: 11643670
    Abstract: Described herein are methods of enhancing chromosomal homologous recombination to stimulate a loss of heterozygosity at a gene locus of interest in a living cell. These methods are driven by an enhancer component and a target-specific endonuclease component and proceed through a mechanism whereby: exogenous donor DNA that is homologous to the gene locus of interest is not introduced into the living cell; the desired allele of the gene locus of interest remains uncleaved; and the undesired allele is either uncleaved, cleaved at a single location, or cleaved at multiple locations. These methods have numerous applications, including the repair of risk alleles for disease prevention, the correction of heterozygous mutations in dividing cells, the design of cancer therapeutics, and the design of novel gene-drive strategies.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 9, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: Guoping Feng, Jonathan Wilde, Tomomi Aida, Martin Wienisch, Qiangge Zhang
  • Patent number: 11642362
    Abstract: The disclosure provides a method of inhibiting proliferation of a cell, inhibiting m3C formation in a cell, inhibiting activity of Mettl8 in a cell, or activating ATM and p53 in a cell, the method comprising contacting the cell with a Mettl8 inhibitor. The disclosure also provides a composition comprising a cell with a reduced expression or activity of Mettl8. In another aspect, the disclosure provides methods of rendering a tumor cell sensitive to a cancer therapy.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: May 9, 2023
    Inventors: Xin-Yuan Fu, Xinyu Liu, Lu Ang Xu
  • Patent number: 11644451
    Abstract: Described herein is a chemical sensing system that can be deployed in an environment and automatically monitor the environment. The chemical sensing system includes one or more chemical sensing units with sensing elements that sense chemicals in the environment. The chemical sensing system analyzes measured values output by the sensing elements to identify patterns indicative of events. After identifying an event, the chemical sensing system may generate an inference about the environment using measured values output by the sensing elements during the event.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: May 9, 2023
    Assignee: Stratuscent, Inc.
    Inventors: Amir Bahador Gahroosi, Neven Maric, Ashok Prabhu Masilamani, Mojtaba Khomami Abadi
  • Patent number: 11644455
    Abstract: Disclosed herein are methods for the detection of the presence of sperm DNA fragmentation in a semen sample. The methods include embedding of sperm cells of the semen sample in a gel, denaturing DNA of the sperm cells, and lysing the nuclear proteins of the sperm cells. The present method includes an ionic surfactant sodium dodycyl sulfate (SDS) and a chaotropic agent urea in the lysis solution for releasing DNA from protamine of chromosome, which significantly reduces the time required for lysis. A kit for detecting sperm DNA fragmentation in a semen sample is also disclosed.
    Type: Grant
    Filed: December 7, 2021
    Date of Patent: May 9, 2023
    Assignee: Bonraybio Co., Ltd.
    Inventors: Cheng-Teng Hsu, Li-Sheng Chang, Hsiu-Chin Lee
  • Patent number: 11640849
    Abstract: The present disclosure provides a diagnostic method based on pairwise comparison of cancers using transcriptome expression data. In one embodiment, the method comprises the steps of: obtaining a first gene expression profile of a first cancer sample having a first cancer type; obtaining a second gene expression profile of a second cancer sample having a second cancer type, wherein the second cancer type is different from the first cancer type; comparing said first gene expression profile with said second gene expression profile; and selecting N genes that are most differentially expressed in the first and the second gene expression profiles to generate pairwise differentially expressed genes (DEGs), wherein N is an integer between 10 and 100.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: May 2, 2023
    Inventors: Sheng Guo, Henry Qixiang Li
  • Patent number: 11634742
    Abstract: Provided herein are double strand DNA molecules comprising inverted repeats, expression cassette and one or more restriction sites for nicking endonucleases, the methods of use thereof, and the methods of making therefor.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: April 25, 2023
    Assignee: Anjarium Biosciences AG
    Inventors: Joel de Beer, Monique Maurer, Nicolas Meier, Lavaniya Kunalingam, Marcello Clerici
  • Patent number: 11633732
    Abstract: Provided herein is a lateral flow diagnostic device and methods of using thereof. The device comprises a substrate and a first end, wherein the first end comprises a sample loading portion. The first end may further comprise a first region loaded with a detectable ligand, a CRISPR effector system, a detection construct, a first test band comprising a biotin ligand, and a second test band comprising a capture molecule for the detectable ligand. The detection construct may comprise an RNA oligonucleotide, having a first molecule such as FITC on a first end and a second molecule such as FAM on a second end. Contacting the sample loading portion with a sample causes the sample to flow from the sample loading portion of the substrate towards the first and second capture regions, thereby generating a detectable signal, which may be indicative of a disease state.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: April 25, 2023
    Assignees: The Broad Institute, Inc., Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: Feng Zhang, Jonathan Gootenberg, Omar Abudayyeh
  • Patent number: 11630066
    Abstract: Optical device for optical fluorescence microscopy, comprising a spatial modulator (1), a microscope objective (2), a beamsplitter (3) and a camera (4), wherein the beamsplitter (3) is placed between the spatial modulator (1) and the microscope objective (2), wherein the beamsplitter (3) is placed between the camera (4) and the microscope objective (2), and wherein a prism (5) is placed between the beamsplitter (3) and the camera (4).
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: April 18, 2023
    Inventors: Vincent Studer, Rémi Galland
  • Patent number: 11629366
    Abstract: There is a method for selective translation of a desired protein. The method has the steps of (a) providing a modified nucleic acid enzyme, including two half cores of a minimized 9DB1 deoxyribozyme split between nucleotides 35 and 39, wherein each half core includes a pendant assembly arm of a strand of nucleic acids extending therefrom and a separate, pendant binding arm extending therefrom of a strand of nucleic acids; (b) binding a nucleic acid ligand to each of the two assembly arms to form an intermediate; (c) binding the intermediate to (i) a first substrate of ribonucleic acid sequences capped at one end, (ii) a second substrate of a strand of ribonucleic acids having a 5? triphosphate region at one end and a region of polyadenylated nucleotides at the other end and wherein the second substrate codes for the desired protein, (iii) join the two half cores to form a core in order to form a ligated product; and (d) allowing the translation for the desired protein to proceed from the ligated product.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: April 18, 2023
    Inventor: Collin Frank Marino
  • Patent number: 11629348
    Abstract: The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: April 18, 2023
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Brooke A. Anderson, Xue-hai Liang, William John Drury, III, Michael Oestergaard, Michael T. Migawa, Punit P. Seth
  • Patent number: 11622972
    Abstract: Provided herein are compositions and methods of reducing adduct formation.
    Type: Grant
    Filed: June 27, 2022
    Date of Patent: April 11, 2023
    Assignee: MODERNATX, INC.
    Inventors: Meredith Packer, Dipendra Gyawali, Serenus Hua, Gabor Butora, Gregory John Mercer
  • Patent number: 11624083
    Abstract: The present invention is a method for measuring the amount of at least one molecule in a biological sample, the method comprising a) combining the sample, or a derivative thereof, with one or more aptamers and allowing one or more molecules in the sample to bind to the aptamer(s); b) separating bound from unbound molecules; and c) quantifying the molecule(s) bound to the or each aptamer, wherein quantification of the bound molecule(s) is carried out by sequencing at least part of the or each aptamer. Uses of and products derived from the method are also contemplated.
    Type: Grant
    Filed: June 13, 2022
    Date of Patent: April 11, 2023
    Assignee: Caris Science, Inc.
    Inventors: Clive Gavin Brown, Koen Kas, Sven Agnes Jan Eyckerman
  • Patent number: 11618029
    Abstract: The present invention provides a system for receiving biological sequence information and activating the synthesis of a biological entity. The system has a receiving unit for receiving a signal encoding biological sequence information transmitted from a transmitting unit. The transmitting unit can be present at a remote location from the receiving unit. The system also has an assembly unit connected to the receiving unit, and the assembly unit assembles the biological entity according to the biological sequence information. Thus, according to the present invention biological sequence information can be digitally transmitted to a remote location and the information converted into a biological entity, for example a protein useful as a vaccine, immediately upon being received by the receiving unit and without further human intervention after preparing the system for receipt of the information.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: April 4, 2023
    Assignee: Telesis Bio Inc.
    Inventors: J. Craig Venter, Daniel Gibson, John E. Gill
  • Patent number: 11612873
    Abstract: Nucleic acid memory strands encoding digital data using a sequence of homopolymer tracts of repeated nucleotides provides a cheaper and faster alternative to conventional digital DNA storage techniques. The use of homopolymer tracts allows for lower fidelity, high throughput sequencing techniques such as nanopore sequencing to read data encoded in the memory strands. Specialized synthesis techniques allow for synthesis of long memory strands capable of encoding large volumes of data despite the reduced data density afforded by homopolymer tracts as compared to conventional single nucleotide sequences.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: March 28, 2023
    Assignee: Molecular Assemblies, Inc.
    Inventors: J. William Efcavitch, Sanjay Agarwalla, Kim Albizati, Alan W. Grubbs, Matthew T. Holden, Patrycja A. Hopkins, Jay K. Singh
  • Patent number: 11603556
    Abstract: Methods and compositions for attaching cell-specific barcodes without formation of partitions is provided.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: March 14, 2023
    Assignee: Bio-Rad Laboratories, Inc.
    Inventor: Ronald Lebofsky
  • Patent number: 11603536
    Abstract: The invention relates to novel maize plants, seeds and compositions, as well as improvements to maize plant breeding and methods for creating modifications in maize plant genomes.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: March 14, 2023
    Inventors: Richard Bailey Flavell, Yajie Niu, Michael Lee Nuccio, Randall William Shultz, Davide Sosso, Maria Margarita D. Unson, John Patrick Casey, Jr., Barry Andrew Martin
  • Patent number: 11603383
    Abstract: The methods described herein provide a means of producing an array of spatially separated proteins. The method relies on covalently attaching each protein of the plurality of proteins to a structured nucleic acid particle (SNAP), and attaching the SNAPs to a solid support.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: March 14, 2023
    Assignee: Nautilus Biotechnology, Inc.
    Inventors: Dmitriy Gremyachinskiy, Rachel Galimidi, Parag Mallick, Sujal M. Patel
  • Patent number: 11604186
    Abstract: A Western Blot assay is performed by performing a probing process on a membrane containing target proteins, by contacting the membrane with a fluorescent resonant energy transfer (FRET) solution and allowing the probing process to proceed for a probing time period. The probing process results in a target protein becoming labeled with both a donor chromophore and an acceptor chromophore, which are effective as a donor-acceptor pair for FRET when so linked to the target protein. While performing the probing process, the labeled target proteins are measured by irradiating the membrane with an excitation light to excite the donor chromophores, wherein in each labeled target protein, the excited donor chromophore transfers energy to the acceptor chromophore by FRET and, in response, the labeled target protein emits an emission light. The intensity of the emission light is then measured. The light measured may be light emitted from the donor chromophore and/or light emitted from the acceptor chromophore.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: March 14, 2023
    Assignee: Molecular Devices (Austria) GmbH
    Inventors: Michael Katzlinger, Kamil Önder
  • Patent number: 11598720
    Abstract: A computer-implemented method for spectroscopic analysis of biological material is provided that includes analyzing samples of biological material from a plurality of sources, and delivering samples of biological material to at least one flow cell for spectroscopy, and determining whether the spectroscopic analysis for each sample of the plurality of samples is or is predicted to be ambiguous in that it is affected by at least two non-discriminable factors. If such a determination is made, a disambiguating step can be performed.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 7, 2023
    Inventors: Adrian Stacey, Christian Grimm, Marek Hoehse, Thomas Regen, Angus Woodhams
  • Patent number: 11597958
    Abstract: The invention relates to a plasmid, a DNA assembly method and its application recombinant strain. The plasmid has single adjacent Type IIP and Type IIS RE recognition sites. The plasmid combines the properties of Type IIP and Type IIS REs to achieve recursive cycling, SCAR-free and repeat sequence assembly.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: March 7, 2023
    Inventors: Shuwen Liu, Tingyi Wen, Yun Zhang, Aihua Deng
  • Patent number: 11597930
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: March 7, 2023
    Assignee: MIRECULE, INC.
    Inventors: Robert Place, Anthony Saleh, Tishan Williams
  • Patent number: 11598768
    Abstract: Compositions comprising multiple hydrogel particles having substantially the same diameter, but with each subgrouping of particles from the multiple hydrogel particles having different associated values for one or more passive optical properties that can be deconvoluted using cytometric instrumentation. Each hydrogel particle from the multiple hydrogel particles can be functionalized with a different biochemical or chemical target from a set of targets. A method of preparing hydrogel particles includes forming droplets and polymerizing the droplets, with optional functionalization.
    Type: Grant
    Filed: May 4, 2021
    Date of Patent: March 7, 2023
    Assignee: Slingshot Biosciences, Inc.
    Inventors: Jeffrey Kim, Anh Tuan Nguyen, Brandon Miller
  • Patent number: 11591641
    Abstract: This invention provides methods of amplifying genomic DNA to obtain an amplified representative population of genome fragments. Methods are further provided for obtaining amplified genomic DNA representations of a desired complexity. The invention further provides methods for simultaneously detecting large numbers of typable loci for an amplified representative population of genome fragments. Accordingly the methods can be used to genotype individuals on a genome-wide scale.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: February 28, 2023
    Assignee: Illumina, Inc.
    Inventors: Kevin L. Gunderson, Frank J. Steemers
  • Patent number: 11591642
    Abstract: Methods and systems described herein involve using long cell-free DNA fragments to analyze a biological sample from a pregnant subject. The status of methylated CpG sites and single nucleotide polymorphisms (SNPs) is often used to analyze DNA fragments of a biological sample. A CpG site and a SNP are typically separated from the nearest CpG site or SNP by hundreds or thousands of base pairs. Finding two or more consecutive CpG sites or SNPs on most cell-free DNA fragments is improbable or impossible. Cell-free DNA fragments longer than 600 bp may include multiple CpG sites and/or SNPs. The presence of multiple CpG sites and/or SNPs on long cell-free DNA fragments may allow for analysis than with short cell-free DNA fragments alone. The long cell-free DNA fragments can be used to identify a tissue of origin and/or to provide information on a fetus in a pregnant female.
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: February 28, 2023
    Assignee: The Chinese University of Hong Kong
    Inventors: Yuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan, Peiyong Jiang, Suk Hang Cheng, Cheuk Yin Yu, Yee Ting Cheung, Wenlei Peng
  • Patent number: 11591646
    Abstract: The present invention may provide a small RNA detection sensor comprising: at one end thereof, a first sensing region comprising nucleotides having a sequence complementary to target small RNA; and a PCR-capable region that is coupled to the first sensing region, the small RNA detection sensor to synthesize a replication region complementary to the PCR-capable region by a DNA polymerase by using the target small RNA as a primer, and amplify the PCR-capable region and the replication region.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: February 28, 2023
    Assignee: XENOHELTX CO., LTD
    Inventors: Seong Wook Yang, Seok Keun Cho, Pratik Shah, Riddhi Nitin Nagda
  • Patent number: 11584958
    Abstract: Aspects of the invention include methods for preparing sequencing libraries, performing sequencing procedures that can correct for process-related errors, and identifying rare variants that are or may be indicative of cancer.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: February 21, 2023
    Assignee: GRAIL, LLC
    Inventors: Arash Jamshidi, Gordon Cann, Hamed Amini, Alex Aravanis
  • Patent number: 11578095
    Abstract: Provided herein are methods and compositions for synthesizing 5?Capped RNAs wherein the initiating capped oligonucleotide primers have the general form m7Gppp[N2?Ome]n[N]m wherein m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, “n” can be any integer from 0 to 4 and “m” can be an integer from 1 to 9.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: February 14, 2023
    Assignee: TriLink Biotechnologies, LLC
    Inventors: Richard I. Hogrefe, Alexandre Lebedev, Anton P. McCaffrey, Dongwon Shin
  • Patent number: 11578355
    Abstract: The present invention relates to a nanoplasmonic biosensor capable of label-free multiplex detection of disease markers in blood with high selectivity and sensitivity and a method for detecting disease markers using the nanoplasmonic biosensor. The nanoplasmonic biosensor of the present invention enables label-free multiplex detection of miRNAs as disease markers in blood with high selectivity and sensitivity. Therefore, the nanoplasmonic biosensor of the present invention can be effectively used for the diagnosis of miRNA-related diseases and clinical applications.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: February 14, 2023
    Assignee: Korea University Research and Business Foundation
    Inventors: Sang Jun Sim, Jong-Uk Lee, Woo-hyun Kim
  • Patent number: 11578331
    Abstract: The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: February 14, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Matthias Schroff, Manuel Schmidt, Kerstin Kapp, Alfredo Zurlo
  • Patent number: 11578320
    Abstract: Disclosed herein, inter alia, are methods and compositions for sequencing a plurality of template nucleic acids.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: February 14, 2023
    Inventors: Eli N. Glezer, Daan Witters, Niek Van Wietmarschen
  • Patent number: 11578354
    Abstract: Provided are devices, systems, and methods for the identification, quantification, and profiling of microscopic organisms. The methods for the identification, quantification, and profiling of microscopic organisms include, for example, the selective enrichment of microscopic organisms from a heterogeneous sample; subsequent loading of the microscopic organisms into microfluidic channels or reaction chambers; direct amplification of nucleic acids from single, isolated microscopic organisms; and examination of amplification products using digital High Resolution Melting (HRM) analysis.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: February 14, 2023
    Assignee: MELIOLABS INC.
    Inventors: Mridu Sinha, Ryan Simkovsky, Kaushik Sridhar, Shubhodeep Paul, Amol Chaudhary
  • Patent number: 11574705
    Abstract: A high-throughput hybridization and reading method for biochips uses probes with different marks to specifically connect single nucleotide loci by conducting connection between the probes and target genes at different temperatures, and performing hybridization at the same temperature after the probes are connected, thereby achieving hybridization detection for various loci in a single chip. The method enables fast detection for multiple loci as required by personalized medicine. The detection is high-throughput and systematized and provides highly visualized and highly accurate results. The method allows detection for different loci at different hybridization temperatures to be done simultaneously. The method features highly uniform and repeatable detection, making biochips more efficient and utility in terms of detection. Besides, the chip is easy to prepare and use, thus having a good promotional value.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: February 7, 2023
    Assignee: First Bioscience Ltd
    Inventors: Zhiyuan Zhu, Libo Chen
  • Patent number: 11567095
    Abstract: A sample rack includes a placement table having an upper surface for placing at least one sample plate thereon, a handle portion holding a proximal end portion of the placement table, the handle portion having a lower end portion positioned lower than a lower surface of the placement table when the upper surface is leveled, and a leg portion attached to the placement table to take a protruding posture in which the leg portion is protruded downward from the lower surface and a storage posture in which the leg portion is not protruded downward from the lower surface. The leg portion is configured to support the sample rack to maintain the upper surface substantially horizontally in cooperation with the lower end portion of the handle portion when the sample rack is placed on a substantially horizontal surface with the leg portion taking the protruding posture.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: January 31, 2023
    Assignee: Shimadzu Corporation
    Inventor: Kenichi Yasunaga
  • Patent number: 11560592
    Abstract: Provided herein are methods for resetting an array to which a biological sample has been applied that include treating the array with a set of biological sample removal conditions.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: January 24, 2023
    Assignee: 10x Genomics, Inc.
    Inventors: Jennifer Chew, Zachary Bent, Alvaro J Gonzalez Lozano
  • Patent number: 11560589
    Abstract: The invention relates to new methods of moving helicases past spacers on polynucleotides and controlling the loading of helicases on polynucleotides. The invention also relates to new methods of characterising target polynucleotides using helicases.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: January 24, 2023
    Assignee: Oxford Nanopore Technologies PLC
    Inventors: Andrew John Heron, David Antoni Alves, James Anthony Clarke, Marion Louise Crawford, Daniel Ryan Garalde, Graham Hall, Daniel John Turner, James White
  • Patent number: 11560565
    Abstract: Described herein are DNA-nanostructures that can be used in an assay to detect and/or quantify an analyte of interest. Aspects of the DNA-nanostructure can include a single DNA molecule composed of hairpin structural motifs, an anchor recognition moiety, and a signal moiety, where the anchor recognition moiety and the signal moiety are in effective proximity to each other such that the tethered diffusion of the signal molecule can be altered based upon binding status of the anchor recognition moiety. Also described herein are methods of making and using the DNA-nanostructures.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: January 24, 2023
    Inventors: Christopher J. Easley, Subramaniam Somasundaram
  • Patent number: 11560595
    Abstract: The method for preventing progression to Type II Diabetes includes determining whether a subject possesses a risk variant expression profile demonstrating dysregulation of the IL-33/ST2 axis, and providing an intervention to prevent progression to Type II Diabetes and/or to reverse prediabetes, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with Type II Diabetes or prediabetes, such as heart disease, stroke, or obesity. The pharmaceutical compound may be one or more pharmaceuticals capable of reducing circulating cholesterol, reducing blood glucose levels, reducing blood pressure, or a combination thereof.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: January 24, 2023
    Inventor: Amal Ahmad Ali Hasan
  • Patent number: 11551782
    Abstract: The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes from a biological sample obtained from a kidney cancer patient. The present invention also provides methods of obtaining a quantitative score for a patient with kidney cancer based on measurement of expression levels of genes from a biological sample obtained from a kidney cancer patient. The genes may be grouped into functional gene subsets for calculating the quantitative score and the gene subsets may be weighted according to their contribution to cancer recurrence.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: January 10, 2023
    Assignee: Genomic Health, Inc.
    Inventors: Steven Shak, George Andrew Watson, Michael R. Crager, Tara Maddala, Margarita Lopatin, Audrey Goddard, Dejan Knezevic, Christer Svedman
  • Patent number: 11547994
    Abstract: A sample of blood is placed on a bilirubin test strip and plasma separated from the red blood cells. The bilirubin test strip is located on a test card along with a set of calibration images, the colors of the calibration images being associated with known plasma bilirubin levels. A photograph is taken of the test card. The bilirubin level of the blood sample is determined by, within the photograph, interpolating the color of the plasma and the colors of the closest colored calibration images.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: January 10, 2023
    Inventors: Richard P. Wennberg, Michael Koenig, Fang Yuan
  • Patent number: 11542535
    Abstract: In some embodiments, the present teachings provide compositions, systems, methods and kits for generating a population of nucleic acid fragments. In some embodiments, nucleic acids can be fragmented enzymatically. For example, methods for generating a population of nucleic acid fragments can include a nucleic acid nicking reaction. In one embodiment, the methods can include a nick translation reaction. A nicking reaction can introduce nicks at random positions on either strand of a double-stranded nucleic acid. A nick translation reaction can move the position of nicks to a new position so that the new positions of two of the nicks are aligned to create a double-stranded break. In some embodiments, methods for generating a population of nucleic acid fragments can include joining at least one end of a fragmented nucleic acid to one or more oligonucleotide adaptors.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: January 3, 2023
    Assignee: Life Technologies Corporation
    Inventors: Zhoutao Chen, Xiaoping Duan, Kyusung Park
  • Patent number: 11542542
    Abstract: The present disclosure relates to improved methods for detecting nucleic acids using DNA fingerloop stem loop structures, wherein the DNA fingerloop stem loop structures diminish base pairing of a detection probe to a mismatched target nucleic acid. The present disclosure also relates to improved methods for amplifying nucleic acids. Further disclosed are chimeric fingerloop DNAs for use in methods for modulating protein expression levels and/or RNA stability.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: January 3, 2023
    Assignee: Ohio State Innovation Foundation
    Inventor: Richard A. Lease
  • Patent number: 11542553
    Abstract: The invention relates to methods for pairwise sequencing of a polynucleotide template which result in the sequential determination of nucleotide sequence in two distinct and separate regions of the polynucleotide template.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: January 3, 2023
    Assignee: Illumina Cambridge Limited
    Inventor: Harold Philip Swerdlow
  • Patent number: 11542540
    Abstract: Provided are methods, as well as compositions, kits, and systems for preparing optimized control nucleic acids (polynucleotides) having reduce nucleic acid damage. Provided nucleic acid compositions provide reduced artifacts as compared to nucleic acid compositions prepared by conventional methods. Provided compositions are useful control in a variety of applications, including, but not limited to sequencing workflows to effectively monitor sensitivity, accuracy and/or precision of data.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: January 3, 2023
    Inventors: Dalia Dhingra, Richard Chien
  • Patent number: 11530441
    Abstract: The methods, compositions, and kits of the disclosure provide a novel approach for a whole genome, unbiased DNA analysis method that can be performed on limited amounts of DNA. can be used to analyze DNA to determine its modification status. Aspects of the disclosure relate to a method for amplifying bisulfite-treated deoxyribonucleic acid (DNA) molecules comprising: (a) ligating an adaptor to the DNA molecules, wherein the adaptor comprises a RNA polymerase promoter comprising bisulfite-protected cytosines; (b) treating the ligated DNA molecules with bisulfite; (c) hybridizing the bisulfite-treated DNA molecules with a primer; (d) extending the hybridized primer to make double stranded DNA; and (e) in vitro transcribing the double-stranded DNA to make RNA.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: December 20, 2022
    Assignee: The University of Chicago
    Inventors: Chuan He, Ji Nie, Xiao-Long Cui
  • Patent number: 11530253
    Abstract: The present disclosure provides genetically modified antibody-producing cells comprising edited chromosomal sequences associated with immunoglobulin heavy chain constant region, the IgH locus. In particular, these cells are generated using a CRISPR/Cas 9-mediated editing process. The disclosure also provides specific guide RNA (gRNA) guide sequences that target the chromosomal sequence of immunoglobulin heavy chain constant region in the Switch regions.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: December 20, 2022
    Inventors: Roberto Chiarle, Taek-Chin Cheong